Nu Skin Enterprises, Inc.NUSNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -8.82% | -12.66% | -12.06% | -15.33% | -16.89% |
| Gross Profit Growth | -20.79% | -16.02% | -13.49% | -14.84% | -6.15% |
| EBITDA Growth | -233.47% | +466.17% | +0.00% | -13.17% | +0.00% |
| Operating Income Growth | -430.46% | -212.25% | +0.00% | +18.71% | +0.00% |
| Net Income Growth | -595.81% | +0.00% | +0.00% | +105.72% | +0.00% |
| EPS Growth | -586.67% | +0.00% | +0.00% | +105.88% | +0.00% |
| EPS Diluted Growth | -586.67% | +0.00% | +0.00% | +100.00% | +0.00% |
| Weighted Average Shares Growth | +0.61% | +0.46% | -0.50% | -0.62% | -2.28% |
| Weighted Average Shares Diluted Growth | +0.47% | +1.59% | -0.38% | +1.16% | +0.40% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -52.40% | -88.28% | -30.10% | -12.57% | -35.54% |
| Free Cash Flow Growth | -60.92% | +0.00% | -16.96% | -23.08% | -55.61% |
| Receivables Growth | -13.48% | -15.61% | -16.56% | -28.95% | -22.13% |
| Inventory Growth | -32.05% | -28.79% | -26.07% | -27.95% | -3.49% |
| Asset Growth | -18.78% | -20.12% | -8.97% | -10.01% | -4.33% |
| Book Value per Share Growth | -21.22% | -7.36% | +15.38% | +13.85% | +26.48% |
| Debt Growth | -21.26% | -46.05% | -41.22% | -41.93% | -23.83% |
| R&D Expense Growth | -42.48% | +0.00% | +0.00% | +0.00% | -16.92% |
| SG&A Expenses Growth | -12.26% | -16.67% | -17.09% | -17.00% | -16.63% |